drugset / Trial / NCT04352361
Ascending Single-dose Study to Evaluate TVB-2640 in Chinese Healthy Subjects
RandomizedParallel-groupSingle-blindTreatment
Summary
Ascending oral single-dose study to evaluate the safety and pharmacokinetics of TVB- 2640 tablets in the Chinese healthy population.
Timeline
- Start
- 2020-04-02
- Primary completion
- 2020-04-29
- Completion
- 2020-04-29
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Denifanstat | Small molecule | 25 mg | Oral |
| Subject | Denifanstat | Small molecule | 50 mg | Oral |
| Subject | Denifanstat | Small molecule | 75 mg | Oral |
Indications
No indication recorded.